Industry: Medical Devices & Consumables
Published Date: 2025-10-10
Pages: 140 Pages
Report ld: 5051876
Request Sample
Customized Report
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Colloidal Gold Immunochromatography Products cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Colloidal Gold Immunochromatography Products sales reached approximately 2,562.66 M units, with an average global market price of around US$1,117 per K units.
Colloidal gold immunochromatography technology has developed rapidly in recent years and has been widely used in the biomedical field, particularly in medical testing. Colloidal gold immunochromatographic test strips primarily coat specific antigens or antibodies in the form of strips on the detection line of a NC membrane. The colloidal gold-labeled antigen or antibody is adsorbed onto a conjugate pad. When the sample is applied to the well at the end of the test strip, it migrates forward through capillary action, dissolving the colloidal gold-labeled antigen or antibody on the conjugate pad and then migrating to the detection line of the coated antigen or antibody. If the sample contains the corresponding antibody or antigen, the antigen or antibody coated on the detection line and the colloidal gold label bind to the corresponding antibody or antigen in the sample, forming an immune complex. The colloidal gold is concentrated at the detection line, forming a visible purple-red line. If the serum tested lacks the corresponding antibody, the colloidal gold label will not bind to the antigen or antibody coated on the detection line, resulting in no colloidal gold accumulation and no purple-red line appearing on the detection line. As the sample and colloidal gold marker continue to move upward to the control line, they bind to specific antibodies or antigens coated there, forming an immune complex and resulting in a purple-red line enriched with colloidal gold.
This detection technology offers advantages such as simplicity and speed, high specificity and sensitivity, single-sample measurement, intuitive results, and the absence of specialized equipment. It is suitable for grassroots units, hospitals, field workers, large-scale testing with tight deadlines, and large-scale surveys, and has enormous development potential and application prospects.
Market Development Opportunities & Main Driving Factors
Colloidal gold immunochromatography products have become increasingly popular as rapid and convenient diagnostic tools worldwide. The high prevalence of infectious diseases, particularly respiratory and gastrointestinal infections, has driven the demand for rapid diagnostic products. Additionally, the growing awareness of health and wellness among consumers has led to a higher acceptance of self-testing products, further expanding the market. Technological advancements, such as multiplex testing capabilities and the proliferation of portable devices, have broadened the application scenarios of these products in clinical, home, and environmental testing. Government emphasis on public health and supportive policies for rapid diagnostic technologies have also provided strong backing for market development.
Market Challenges, Risks, & Restraints
Despite the promising market outlook, colloidal gold immunochromatography products face several challenges and risks. Firstly, issues related to quality control and standardization need further attention, especially concerning product consistency across different regions and manufacturers. Secondly, the increasing number of homogeneous products in the market has intensified price competition, potentially impacting profit margins. Moreover, consumers' rising expectations for product accuracy and reliability require continuous investment in research and development to enhance product performance and meet market demands. Lastly, global supply chain instabilities, particularly concerning raw materials and production capacities, may affect market supply.
Downstream Demand Trends
Downstream demand is exhibiting diversification and personalization trends. The clinical diagnostics sector continues to require rapid and accurate testing products, especially in emergency and primary healthcare settings. The home self-testing market is also expanding rapidly, with consumers seeking convenient health monitoring solutions. Environmental monitoring and food safety sectors are increasing their demand for rapid testing technologies, driving the application of related products. With the widespread adoption of health management concepts, colloidal gold immunochromatography products are expected to extend beyond disease diagnosis to encompass health monitoring and disease prevention, further enriching market demand.
This report aims to provide a comprehensive presentation of the global market for Colloidal Gold Immunochromatography Products, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Colloidal Gold Immunochromatography Products by region & country, by Type, and by Application.
The Colloidal Gold Immunochromatography Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloidal Gold Immunochromatography Products.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Colloidal Gold Immunochromatography Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Colloidal Gold Immunochromatography Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Colloidal Gold Immunochromatography Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Colloidal Gold Immunochromatography Products Product Introduction
1.2 Global Colloidal Gold Immunochromatography Products Market Size Forecast
1.2.1 Global Colloidal Gold Immunochromatography Products Sales Value (2020-2031)
1.2.2 Global Colloidal Gold Immunochromatography Products Sales Volume (2020-2031)
1.2.3 Global Colloidal Gold Immunochromatography Products Sales Price (2020-2031)
1.3 Colloidal Gold Immunochromatography Products Market Trends & Drivers
1.3.1 Colloidal Gold Immunochromatography Products Industry Trends
1.3.2 Colloidal Gold Immunochromatography Products Market Drivers & Opportunity
1.3.3 Colloidal Gold Immunochromatography Products Market Challenges
1.3.4 Colloidal Gold Immunochromatography Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Colloidal Gold Immunochromatography Products Players Revenue Ranking (2024)
2.2 Global Colloidal Gold Immunochromatography Products Revenue by Company (2020-2025)
2.3 Global Colloidal Gold Immunochromatography Products Players Sales Volume Ranking (2024)
2.4 Global Colloidal Gold Immunochromatography Products Sales Volume by Company Players (2020-2025)
2.5 Global Colloidal Gold Immunochromatography Products Average Price by Company (2020-2025)
2.6 Key Manufacturers Colloidal Gold Immunochromatography Products Manufacturing Base and Headquarters
2.7 Key Manufacturers Colloidal Gold Immunochromatography Products Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Colloidal Gold Immunochromatography Products
2.9 Colloidal Gold Immunochromatography Products Market Competitive Analysis
2.9.1 Colloidal Gold Immunochromatography Products Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Colloidal Gold Immunochromatography Products Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloidal Gold Immunochromatography Products as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Drug and Drug Test Strips & Kits
3.1.2 Infectious Disease Test Strips & Kits
3.1.3 Cardiac Marker Test Strips & Kits
3.1.4 Tumor Marker Detection Test Strips & Kits
3.1.5 Others
3.2 Global Colloidal Gold Immunochromatography Products Sales Value by Type
3.2.1 Global Colloidal Gold Immunochromatography Products Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Colloidal Gold Immunochromatography Products Sales Value, by Type (2020-2031)
3.2.3 Global Colloidal Gold Immunochromatography Products Sales Value, by Type (%) (2020-2031)
3.3 Global Colloidal Gold Immunochromatography Products Sales Volume by Type
3.3.1 Global Colloidal Gold Immunochromatography Products Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Colloidal Gold Immunochromatography Products Sales Volume, by Type (2020-2031)
3.3.3 Global Colloidal Gold Immunochromatography Products Sales Volume, by Type (%) (2020-2031)
3.4 Global Colloidal Gold Immunochromatography Products Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Domestic
4.1.3 Others
4.2 Global Colloidal Gold Immunochromatography Products Sales Value by Application
4.2.1 Global Colloidal Gold Immunochromatography Products Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Colloidal Gold Immunochromatography Products Sales Value, by Application (2020-2031)
4.2.3 Global Colloidal Gold Immunochromatography Products Sales Value, by Application (%) (2020-2031)
4.3 Global Colloidal Gold Immunochromatography Products Sales Volume by Application
4.3.1 Global Colloidal Gold Immunochromatography Products Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Colloidal Gold Immunochromatography Products Sales Volume, by Application (2020-2031)
4.3.3 Global Colloidal Gold Immunochromatography Products Sales Volume, by Application (%) (2020-2031)
4.4 Global Colloidal Gold Immunochromatography Products Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Colloidal Gold Immunochromatography Products Sales Value by Region
5.1.1 Global Colloidal Gold Immunochromatography Products Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Colloidal Gold Immunochromatography Products Sales Value by Region (2020-2025)
5.1.3 Global Colloidal Gold Immunochromatography Products Sales Value by Region (2026-2031)
5.1.4 Global Colloidal Gold Immunochromatography Products Sales Value by Region (%), (2020-2031)
5.2 Global Colloidal Gold Immunochromatography Products Sales Volume by Region
5.2.1 Global Colloidal Gold Immunochromatography Products Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Colloidal Gold Immunochromatography Products Sales Volume by Region (2020-2025)
5.2.3 Global Colloidal Gold Immunochromatography Products Sales Volume by Region (2026-2031)
5.2.4 Global Colloidal Gold Immunochromatography Products Sales Volume by Region (%), (2020-2031)
5.3 Global Colloidal Gold Immunochromatography Products Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
5.4.2 North America Colloidal Gold Immunochromatography Products Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
5.5.2 Europe Colloidal Gold Immunochromatography Products Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
5.6.2 Asia Pacific Colloidal Gold Immunochromatography Products Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
5.7.2 South America Colloidal Gold Immunochromatography Products Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
5.8.2 Middle East & Africa Colloidal Gold Immunochromatography Products Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Colloidal Gold Immunochromatography Products Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Colloidal Gold Immunochromatography Products Sales Value and Sales Volume
6.2.1 Key Countries/Regions Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.2.2 Key Countries/Regions Colloidal Gold Immunochromatography Products Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.3.2 United States Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.4.2 Europe Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.5.2 China Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.5.3 China Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.6.2 Japan Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.7.2 South Korea Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.8.2 Southeast Asia Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Colloidal Gold Immunochromatography Products Sales Value, 2020-2031
6.9.2 India Colloidal Gold Immunochromatography Products Sales Value by Type (%), 2024 VS 2031
6.9.3 India Colloidal Gold Immunochromatography Products Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Colloidal Gold Immunochromatography Products Product Offerings
7.1.5 Abbott Recent Development
7.2 Wondfo Biotech
7.2.1 Wondfo Biotech Company Information
7.2.2 Wondfo Biotech Introduction and Business Overview
7.2.3 Wondfo Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Wondfo Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.2.5 Wondfo Biotech Recent Development
7.3 ALLTEST BIOTECH
7.3.1 ALLTEST BIOTECH Company Information
7.3.2 ALLTEST BIOTECH Introduction and Business Overview
7.3.3 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Product Offerings
7.3.5 ALLTEST BIOTECH Recent Development
7.4 Orient Gene Biotech
7.4.1 Orient Gene Biotech Company Information
7.4.2 Orient Gene Biotech Introduction and Business Overview
7.4.3 Orient Gene Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Orient Gene Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.4.5 Orient Gene Biotech Recent Development
7.5 Innovita Biological
7.5.1 Innovita Biological Company Information
7.5.2 Innovita Biological Introduction and Business Overview
7.5.3 Innovita Biological Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Innovita Biological Colloidal Gold Immunochromatography Products Product Offerings
7.5.5 Innovita Biological Recent Development
7.6 Ihealth (Andon Health)
7.6.1 Ihealth (Andon Health) Company Information
7.6.2 Ihealth (Andon Health) Introduction and Business Overview
7.6.3 Ihealth (Andon Health) Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ihealth (Andon Health) Colloidal Gold Immunochromatography Products Product Offerings
7.6.5 Ihealth (Andon Health) Recent Development
7.7 Hotgen Biotech
7.7.1 Hotgen Biotech Company Information
7.7.2 Hotgen Biotech Introduction and Business Overview
7.7.3 Hotgen Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hotgen Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.7.5 Hotgen Biotech Recent Development
7.8 Hangzhou Biotest Biotech
7.8.1 Hangzhou Biotest Biotech Company Information
7.8.2 Hangzhou Biotest Biotech Introduction and Business Overview
7.8.3 Hangzhou Biotest Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hangzhou Biotest Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.8.5 Hangzhou Biotest Biotech Recent Development
7.9 Assure Tech
7.9.1 Assure Tech Company Information
7.9.2 Assure Tech Introduction and Business Overview
7.9.3 Assure Tech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Assure Tech Colloidal Gold Immunochromatography Products Product Offerings
7.9.5 Assure Tech Recent Development
7.10 Lepu Medical
7.10.1 Lepu Medical Company Information
7.10.2 Lepu Medical Introduction and Business Overview
7.10.3 Lepu Medical Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Lepu Medical Colloidal Gold Immunochromatography Products Product Offerings
7.10.5 Lepu Medical Recent Development
7.11 Wantai Biological
7.11.1 Wantai Biological Company Information
7.11.2 Wantai Biological Introduction and Business Overview
7.11.3 Wantai Biological Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Wantai Biological Colloidal Gold Immunochromatography Products Product Offerings
7.11.5 Wantai Biological Recent Development
7.12 Bioperfectus
7.12.1 Bioperfectus Company Information
7.12.2 Bioperfectus Introduction and Business Overview
7.12.3 Bioperfectus Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Bioperfectus Colloidal Gold Immunochromatography Products Product Offerings
7.12.5 Bioperfectus Recent Development
7.13 Bioscience
7.13.1 Bioscience Company Information
7.13.2 Bioscience Introduction and Business Overview
7.13.3 Bioscience Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Bioscience Colloidal Gold Immunochromatography Products Product Offerings
7.13.5 Bioscience Recent Development
7.14 Getein Biotech
7.14.1 Getein Biotech Company Information
7.14.2 Getein Biotech Introduction and Business Overview
7.14.3 Getein Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Getein Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.14.5 Getein Biotech Recent Development
7.15 YHLO Biotech
7.15.1 YHLO Biotech Company Information
7.15.2 YHLO Biotech Introduction and Business Overview
7.15.3 YHLO Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 YHLO Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.15.5 YHLO Biotech Recent Development
7.16 BGI Genomics
7.16.1 BGI Genomics Company Information
7.16.2 BGI Genomics Introduction and Business Overview
7.16.3 BGI Genomics Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 BGI Genomics Colloidal Gold Immunochromatography Products Product Offerings
7.16.5 BGI Genomics Recent Development
7.17 Easydiagnosis Biomedicine
7.17.1 Easydiagnosis Biomedicine Company Information
7.17.2 Easydiagnosis Biomedicine Introduction and Business Overview
7.17.3 Easydiagnosis Biomedicine Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Easydiagnosis Biomedicine Colloidal Gold Immunochromatography Products Product Offerings
7.17.5 Easydiagnosis Biomedicine Recent Development
7.18 Vazyme Biotech
7.18.1 Vazyme Biotech Company Information
7.18.2 Vazyme Biotech Introduction and Business Overview
7.18.3 Vazyme Biotech Colloidal Gold Immunochromatography Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Vazyme Biotech Colloidal Gold Immunochromatography Products Product Offerings
7.18.5 Vazyme Biotech Recent Development
8 Industry Chain Analysis
8.1 Colloidal Gold Immunochromatography Products Industrial Chain
8.2 Colloidal Gold Immunochromatography Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Colloidal Gold Immunochromatography Products Sales Model
8.5.2 Sales Channel
8.5.3 Colloidal Gold Immunochromatography Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Colloidal Gold Immunochromatography Products market size was US$ 2501 million in 2025 and is forecast to reach a readjusted size of US$ 3152 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 106
USD 4250.00
(Single User License)
The global Colloidal Gold Immunochromatography Products market was valued at US$ 2501 million in 2025 and is anticipated to reach US$ 3152 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 130
USD 2900.00
(Single User License)
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2501 million in 2025 and is projected to reach US$ 3152 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 132
USD 3950.00
(Single User License)
The global Colloidal Gold Immunochromatography Products market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-21
Pages: 101
USD 4250.00
(Single User License)
The global Colloidal Gold Immunochromatography Products market is projected to grow from US$ 2864 million in 2024 to US$ 3058 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-21
Pages: 179
USD 4900.00
(Single User License)
The global market for Colloidal Gold Immunochromatography Products was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 3058 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-09-21
Pages: 105
USD 2900.00
(Single User License)
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 155
USD 3950.00
(Single User License)
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published Date: 2024-04-28
Pages: 129
USD 4900.00
(Single User License)
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published Date: 2024-02-05
Pages: 113
USD 2900.00
(Single User License)
The global Colloidal Gold Immunochromatography Products market size was US$ 2501 million in 2025 and is forecast to reach a readjusted size of US$ 3152 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 106
The global Colloidal Gold Immunochromatography Products market was valued at US$ 2501 million in 2025 and is anticipated to reach US$ 3152 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 130
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2501 million in 2025 and is projected to reach US$ 3152 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 132
The global Colloidal Gold Immunochromatography Products market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-21
Pages: 101
The global Colloidal Gold Immunochromatography Products market is projected to grow from US$ 2864 million in 2024 to US$ 3058 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-21
Pages: 179
The global market for Colloidal Gold Immunochromatography Products was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 3058 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-09-21
Pages: 105
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 155
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published: 2024-04-28
Pages: 129
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published: 2024-02-05
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now